4//SEC Filing
SCANGOS GEORGE A 4
Accession 0001628280-25-006516
CIK 0001706431other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 7:11 PM ET
Size
9.2 KB
Accession
0001628280-25-006516
Insider Transaction Report
Form 4
SCANGOS GEORGE A
Director
Transactions
- Sale
Common Stock
2025-02-18$9.81/sh−10,964$107,575→ 708,295 total
Holdings
- 33,629(indirect: See footnote)
Common Stock
- 1,151,730(indirect: See footnote)
Common Stock
- 598,270(indirect: See footnote)
Common Stock
- 1,151,730(indirect: See footnote)
Common Stock
- 179,930(indirect: See footnote)
Common Stock
Footnotes (6)
- [F1]Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.
- [F2]The shares are held in the name of the George A Scangos 2023 Annuity Trust, of which the reporting person and his spouse are Trustees.
- [F3]The shares are held by the spouse of the Reporting Person.
- [F4]The shares are held in the name of Leslie Wilson 2023 Annuity Trust, of which the reporting person and his spouse are Trustees.
- [F5]The shares are held in the name of George A. Scangos, as Trustee of the Scangos-Wilson Family Trust dated May 12, 2011.
- [F6]The shares are held in the name of the Scangos 2018 Grandchildren's Trust, of which the reporting person and his spouse are Trustees.
Documents
Issuer
Vir Biotechnology, Inc.
CIK 0001706431
Entity typeother
Related Parties
1- filerCIK 0001202102
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 7:11 PM ET
- Size
- 9.2 KB